Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,819
Total Claims
$1.4M
Drug Cost
627
Beneficiaries
$2,178
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+104%
Cost per patient vs peers
$2,178 vs $1,068 avg
+37%
Brand preference vs peers
12.3% vs 9.0% avg
Brand vs Generic
Brand: 1,559 claims · $1.1M
Generic: 11,102 claims · $302K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 83 | $112K |
| Apixaban | 123 | $103K |
| Dulaglutide | 57 | $62K |
| Tirzepatide | 46 | $59K |
| Insulin Lispro | 60 | $52K |
| Insulin Glargine,hum.Rec.Anlog | 73 | $50K |
| Sitagliptin Phosphate | 37 | $50K |
| Empagliflozin | 37 | $38K |
| Liraglutide | 18 | $37K |
| Linaclotide | 34 | $34K |
| Ipratropium/Albuterol Sulfate | 37 | $26K |
| Rivaroxaban | 24 | $19K |
| Budesonide/Formoterol Fumarate | 28 | $16K |
| Tiotropium Bromide | 23 | $16K |
| Semaglutide | 13 | $15K |
Prescribing Profile
Patient Profile
72
Avg Age
57%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data